https://news.alfafinderusa.com/news/atii-holdings-amends-100-million-pipe-deal-forge-nano-merger/ALFA USA Newsen2026-10-13T16:19:36-04:00ATII Holdings Amends $100 Million PIPE Deal for Forge Nano Mergerhttps://news.alfafinderusa.com/news/qums-fortune-favor-merger-600-million/ALFA USA Newsen2026-10-13T16:07:36-04:00Quantumsphere Acquisition Corp to Merge with Fortune Favor in $600 Million Dealhttps://news.alfafinderusa.com/news/ssr-mining-roxmore-resources-acquisition-nevada-gold-synergies/ALFA USA Newsen2026-10-13T10:22:41-04:00SSR Mining to Acquire Roxmore Resources in $464 Million Strategic Nevada Expansionhttps://news.alfafinderusa.com/news/ithaca-holdings-to-acquire-bumble-inc-1-3-billion-cash-deal/ALFA USA Newsen2026-10-13T10:10:10-04:00Bumble Shares Skyrocket 56% After Ithaca Holdings to Acquire Company in $1.3 Billion Dealhttps://news.alfafinderusa.com/news/ondas-inc-q2-2026-earnings-revenue-growth-guidance-update/ALFA USA Newsen2026-10-13T09:57:40-04:00Ondas Inc. Reports Q2 Revenue Surge to $83.8 Million and Raises 2026 Guidancehttps://news.alfafinderusa.com/news/ondas-palantir-launch-regna-ai-sovereign-defense-intelligence/ALFA USA Newsen2026-10-13T09:42:55-04:00Ondas Inc. and Palantir Launch Regna AI to Deliver Sovereign Defense Intelligencehttps://news.alfafinderusa.com/news/sab-biotherapeutics-sabs-fda-fast-track-sab-142-diabetes-immunotherapy/ALFA USA Newsen2026-10-13T09:29:25-04:00SAB Biotherapeutics (SABS) Secures FDA Fast Track for SAB-142 Diabetes Immunotherapyhttps://news.alfafinderusa.com/news/first-tracks-biotherapeutics-trax-celiac-disease-phase-1b-data/ALFA USA Newsen2026-10-13T09:15:25-04:00First Tracks Biotherapeutics Shares Surge 6.91% on Positive Phase 1b Celiac Disease Datahttps://news.alfafinderusa.com/news/eightco-holdings-orbs-nasdaq-compliance-october-2026/ALFA USA Newsen2026-10-13T09:03:25-04:00Eightco Holdings Inc. Regains Nasdaq Compliance After Ten-Day $1.00 Price Streakhttps://news.alfafinderusa.com/news/mirum-pharmaceuticals-mirm-phase-3-expand-results-livmarli-2026/ALFA USA Newsen2026-10-13T08:48:25-04:00Mirum Pharmaceuticals Meets Phase 3 EXPAND Endpoints for LIVMARLI; sNDA Planned for 2027https://news.alfafinderusa.com/news/kimberly-clark-kenvue-acquisition-7-billion-debt-exchange/ALFA USA Newsen2026-10-13T08:33:25-04:00Kimberly-Clark Advances $48.7 Billion Kenvue Acquisition with $7 Billion Debt Exchangehttps://news.alfafinderusa.com/news/ttm-technologies-q2-2026-earnings-analysis-data-center-growth/ALFA USA Newsen2026-10-13T08:20:25-04:00TTM Technologies Reports Record Q2 2026 Revenue of $1 Billion Amid Data Center Surgehttps://news.alfafinderusa.com/news/norris-industries-q2-2026-results-analysis/ALFA USA Newsen2026-10-13T08:09:55-04:00Norris Industries Reports $0.09 Million Q2 Revenue Amid Widening Net Losshttps://news.alfafinderusa.com/news/adct-therapeutics-capital-raise-86-million-zynlonta-pipeline/ALFA USA Newsen2026-10-13T07:56:25-04:00ADC Therapeutics Secures $86.6 Million PIPE to Extend Cash Runway into 2029https://news.alfafinderusa.com/news/nurix-therapeutics-q3-2026-results/ALFA USA Newsen2026-10-13T07:43:25-04:00Nurix Therapeutics Swings to $549.8M Net Income in Q3 2026 on License Revenue Surgehttps://news.alfafinderusa.com/news/ionq-q2-2026-revenue-growth-skywater-acquisition/ALFA USA Newsen2026-10-13T07:32:55-04:00IonQ Reports 287 Percent Revenue Surge to $80.1 Million Following SkyWater Mergerhttps://news.alfafinderusa.com/news/oz-vision-inc-fy-2026-financial-results/ALFA USA Newsen2026-10-13T07:22:24-04:00OZ Vision Inc. Reports $0.05 Million Revenue and 10.6% Net Loss Improvement for FY 2026https://news.alfafinderusa.com/news/ttm-technologies-400-million-ai-infrastructure-expansion-china-malaysia/ALFA USA Newsen2026-10-13T07:07:54-04:00TTM Technologies Shares Rise 5% After Investing $400 Million to Scale AI Infrastructurehttps://news.alfafinderusa.com/news/dominos-pizza-dpz-q3-2026-financial-results/ALFA USA Newsen2026-10-13T06:56:24-04:00Domino's Pizza Reports $1.19 Billion Revenue and 9.2% Net Income Growth for Q3 2026https://news.alfafinderusa.com/news/humana-blackrock-centerwell-partnership-2-8-billion-joint-venture/ALFA USA Newsen2026-10-13T06:42:24-04:00Humana Partners with BlackRock in $2.8 Billion CenterWell Primary Care Joint Venturehttps://news.alfafinderusa.com/news/ionq-acquires-elisity-1-3-billion-quantum-security-deal/ALFA USA Newsen2026-10-13T06:27:24-04:00IonQ to Acquire Zero Trust Leader Elisity in $1.3 Billion All-Stock Transactionhttps://news.alfafinderusa.com/news/zhanling-international-ltd-q1-2026-results/ALFA USA Newsen2026-10-13T06:15:54-04:00Zhanling International Ltd Narrowed Net Loss to $0.01 Million in Q1 2026https://news.alfafinderusa.com/news/zenas-biopharma-zbio-obexelimab-phase-3-indigo-data-igg4-rd/ALFA USA Newsen2026-10-13T06:04:24-04:00Zenas BioPharma Reports 93% Flare-Free Rate in Phase 3 INDIGO Extension Study